signal/raiseTrack rounds

4BIO Capital

Focus: Healthtech & bio

4BIO Capital took part in 2 of the startup funding rounds we tracked in 2026, leading or co-leading 1 worth $60m. By money raised, its biggest sector was Healthtech & bio. The largest was Estuary Biotherapeutics's $93m Series A round. The most recent was Oyster Therapeutics's Series A round in November 2026.

Deployed as lead$60m
Rounds led1
Rounds joined2
Largest round$93m